Borken

Germany

4 total trials

Filter these 4 trials by phase, condition, sponsor and more.

Open in Search →

Efficacy and Tolerability of AP707 in Patients with chronic Pain due to Diabetic Polyneuropathy Ended

2022-500897-32-00 5 2023-11-02 Chronic pain due to diabetic polyneuropathy
Efficacy and Tolerability of AP707 in Patients with chronic Pain due to traumatic or post-operative peripheral Neuropathy Ended

2022-500898-13-00 5 2023-11-02 Chronic Pain due to traumatic or post-operative peripheral Neuropathy
Efficacy and Tolerability of AP707 in Patients with chronic pain due to central Neuropathy of any Genesis Ended

2022-500899-66-00 5 2023-11-02 Chronic pain due to central Neuropathy of any Genesis
Efficacy and Tolerability of AP707 in Patients with Chronic Back Pain Ended

2022-502151-54-00 5 2023-11-02 Chronic back pain

Showing 1–4 of 4 trials